Juhan I, Vague P, Buonocore M, Moulin J P, Calas M F, Vialettes B, Verdot J J
Scand J Clin Lab Invest Suppl. 1981;156:159-64. doi: 10.3109/00365518109097451.
Erythrocyte deformability was studied by the filtration technique of Reid & Dormandy using whole blood and washed erythrocytes from insulin-dependent diabetics (IDD) under insulin delivery by an artificial pancreas (AP). The same technique was employed to study deformability in vitro using normal erythrocytes incubated in the presence of insulin. Results of this study show that in IDD the initially poor erythrocyte deformability is improved within hours of insulin administration. Improved deformability was accompanied by increased levels of intra-erythrocyte ATP but without changes in levels of HbG and 23 DPG. Incubation of erythrocytes in medium containing glucose showed that deformability was significantly improved in the presence of insulin. These results indicate that insulin favourably affects erythrocyte deformability in IDD. Before and after 24 hours treatment by AP, platelet aggregation was studied in IDD by the technique of Born using platelet-rich plasma (PRP) and by a modified Breddin technique using PRP, whole blood or whole blood treated by chlorpromazine and mixtures of erythrocytes from IDD with normal PRP. Platelet hyperaggregation was only found in the presence of erythrocytes from untreated diabetics. Chlorpromazine, at a dose (10 mumole) which inhibits haemolysis without inducing platelet hyperaggregation, eliminated the above anomaly. In conclusion, it is conceivable that the insulin-induced correction of poor erythrocyte deformability eliminates excessive fragility of erythrocytes and their haemolysis wit release of ADP, thus avoiding platelet hyperaggregation.
采用里德和多尔曼迪的过滤技术,利用全血和来自胰岛素依赖型糖尿病患者(IDD)的洗涤红细胞,在人工胰腺(AP)输注胰岛素的情况下,研究红细胞变形性。采用相同技术,使用在胰岛素存在下孵育的正常红细胞,在体外研究变形性。本研究结果表明,在IDD患者中,最初较差的红细胞变形性在胰岛素给药数小时内得到改善。变形性的改善伴随着红细胞内ATP水平的升高,但血红蛋白G(HbG)和2,3-二磷酸甘油酸(23 DPG)水平没有变化。在含葡萄糖的培养基中孵育红细胞表明,在胰岛素存在下变形性显著改善。这些结果表明,胰岛素对IDD患者的红细胞变形性有有利影响。在AP治疗24小时前后,通过博恩技术使用富含血小板血浆(PRP)以及通过改良的布雷丁技术使用PRP、全血或经氯丙嗪处理的全血,以及IDD患者的红细胞与正常PRP的混合物,研究了IDD患者的血小板聚集情况。仅在未治疗糖尿病患者的红细胞存在时发现血小板高聚集。氯丙嗪以抑制溶血而不诱导血小板高聚集的剂量(10微摩尔)消除了上述异常。总之,可以想象,胰岛素诱导的红细胞变形性差的纠正消除了红细胞的过度脆性及其溶血以及ADP的释放,从而避免了血小板高聚集。